RT Journal Article
SR Electronic
T1 Making an equal system equitable: Proposing a sex-adjusted MELDNa score for liver transplantation allocation
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.12.21260196
DO 10.1101/2021.07.12.21260196
A1 Julia M. Sealock
A1 Ioannis A. Ziogas
A1 Zhiguo Zhao
A1 Fei Ye
A1 Sophoclis P. Alexopoulos
A1 Lea Matsuoka
A1 Guanhua Chen
A1 Lea K. Davis
YR 2021
UL http://medrxiv.org/content/early/2021/07/15/2021.07.12.21260196.abstract
AB Background & Aims Liver allocation is determined by the model for end-stage liver disease (MELD), a scoring system based on four laboratory measurements. During the MELD era, sex disparities in liver transplant have increased and there are no modifications to MELD based on sex. We use data from electronic health records (EHRs) to describe sex differences in MELD labs and propose a sex adjustment.Methods We extracted lab values for creatinine, International Normalized Ratio of prothrombin rate, bilirubin, and sodium from EHRs at Vanderbilt University Medical Center (VUMC) and the All of Us Research Project to determine sex differences in lab traits. We calculated MELDNa scores within liver transplant recipients, non-transplanted liver disease cases, and non-liver disease controls separately. To account for sex differences in lab traits in MELDNa scoring, we created a sex-adjusted MELDNa map which outputs adjusted female scores mapped to male scores of equal liver disease severity. Using waitlist data from the Liver Simulated Allocation Modeling, we conducted simulations to determine if the sex-adjusted scores reduced sex disparities.Results All component MELDNa lab values and calculated MELDNa scores yielded significant sex differences within VUMC (n=623,931) and All of Us (n=56,715) resulting in MELDNa scoring that disadvantaged females who, despite greater decompensation traits, had lower MELDNa scores. In simulations, the sex-adjusted MELDNa score modestly increased female transplantation rate and decreased overall death.Conclusions Our results demonstrate pervasive sex differences in all labs used in MELDNa scoring and highlight the need and utility of a sex-adjustment to the MELDNa protocol.Lay Summary Liver transplant waitlist position is determined by a score called MELDNa, which is calculated using four laboratory values. Once on the waitlist, males are more likely to receive a transplant, while females are more likely to die or be removed due to illness. We demonstrate that all four laboratory values in the MELDNa score show significant sex differences that disadvantage females in liver transplant. We created a sex-adjusted score that increases female transplantation rate and decreases death among both sexes in simulations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementLKD was supported by grants from the National Institutes of Health including U54MD010722-04, U01HG009086, R01MH118223, and R56MH120736.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was deemed non-human subjects research by the VUMC Institutional Review Board (IRB#172020).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSummary level data is available in the Supplementary Information.MELDmodel for end-stage liver diseaseINRinternational normalized ratioOPTNOrgan Procurement and Transplantation NetworkeGFRestimated glomerular filtration rateVUMCVanderbilt University Medical CenterEHRelectronic health recordICDInternational Classification of DiseaseCPTCurrent Procedural TerminologyUNOSUnited Network for Organ SharingLSAMLiver Simulated Allocation Modeling